社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
老油条的原则
IP属地：云南
+关注
帖子 · 175
帖子 · 175
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
老油条的原则
老油条的原则
·
09-01 10:51
$同源康医药-B(02410)$
甲磺酸氘申艾替尼片的成功获批，是公司从临床开发迈向商业化的重要里程碑，也是对同源康创新研发能力的有力印证，标志着我们在攻克肺癌治疗瓶颈上迈出了坚实一步
看
164
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
09-01 10:51
$正力新能(03677)$
从2024年实现扭亏为盈，到2025年盈利能力显著提升，再到2026年上半年收入利润双增长，正力新能正持续夯实规模、效率与质量并重的发展基础
看
52
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
09-01 10:50
$海致科技集团(02706)$
从财报披露的信息来看，海致从项目交付者向连接模型与产业生产系统的基础设施提供者演进的路径，正在逐步清晰
看
281
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
08-18
$正力新能(03677)$
正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段
看
714
回复
评论
点赞
1
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
08-18
$同源康医药-B(02410)$
同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%
看
519
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
08-18
$海致科技集团(02706)$
从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线
看
467
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-30
$同源康医药-B(02410)$
同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来
看
861
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-30
$海致科技集团(02706)$
今天港股形势还可以，海致什么时候来个触底大反弹呢
看
590
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-21
$凯乐士科技(02729)$
根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司
看
712
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
老油条的原则
老油条的原则
·
07-21
$同源康医药-B(02410)$
同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块
看
881
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"156361281180936","uuid":"156361281180936","gmtCreate":1607589937531,"gmtModify":1646408619245,"name":"老油条的原则","pinyin":"lytdyzlaoyoutiaodeyuanze","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":10,"tweetSize":175,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":1},"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"云南","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602907257922296,"gmtCreate":1788231109461,"gmtModify":1788231111812,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 甲磺酸氘申艾替尼片的成功获批，是公司从临床开发迈向商业化的重要里程碑，也是对同源康创新研发能力的有力印证，标志着我们在攻克肺癌治疗瓶颈上迈出了坚实一步","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 甲磺酸氘申艾替尼片的成功获批，是公司从临床开发迈向商业化的重要里程碑，也是对同源康创新研发能力的有力印证，标志着我们在攻克肺癌治疗瓶颈上迈出了坚实一步","text":"$同源康医药-B(02410)$ 甲磺酸氘申艾替尼片的成功获批，是公司从临床开发迈向商业化的重要里程碑，也是对同源康创新研发能力的有力印证，标志着我们在攻克肺癌治疗瓶颈上迈出了坚实一步","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602907257922296","isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602937105166912,"gmtCreate":1788231085818,"gmtModify":1788231088194,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 从2024年实现扭亏为盈，到2025年盈利能力显著提升，再到2026年上半年收入利润双增长，正力新能正持续夯实规模、效率与质量并重的发展基础","listText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 从2024年实现扭亏为盈，到2025年盈利能力显著提升，再到2026年上半年收入利润双增长，正力新能正持续夯实规模、效率与质量并重的发展基础","text":"$正力新能(03677)$ 从2024年实现扭亏为盈，到2025年盈利能力显著提升，再到2026年上半年收入利润双增长，正力新能正持续夯实规模、效率与质量并重的发展基础","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602937105166912","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602906918748176,"gmtCreate":1788231024952,"gmtModify":1788231026993,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从财报披露的信息来看，海致从项目交付者向连接模型与产业生产系统的基础设施提供者演进的路径，正在逐步清晰","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从财报披露的信息来看，海致从项目交付者向连接模型与产业生产系统的基础设施提供者演进的路径，正在逐步清晰","text":"$海致科技集团(02706)$ 从财报披露的信息来看，海致从项目交付者向连接模型与产业生产系统的基础设施提供者演进的路径，正在逐步清晰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602906918748176","isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598021603038528,"gmtCreate":1787019590630,"gmtModify":1787019592583,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","listText":"<a href=\"https://laohu8.com/S/03677\">$正力新能(03677)$ </a> 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","text":"$正力新能(03677)$ 正力现在是需要更多的资金流入进来，这样才会把股价修正，目前还是处于被严重低估阶段","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021603038528","isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598021697139712,"gmtCreate":1787019554424,"gmtModify":1787019556654,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","text":"$同源康医药-B(02410)$ 同源康医药公布2026年中期业绩，研发成本为9494.3万元，同比增长7%;行政开支6255.4万元，同比增长61.3%;母公司拥有人应占亏损2489.7万元，同比收窄77.81%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021697139712","isVote":1,"tweetType":1,"viewCount":519,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":598021342016776,"gmtCreate":1787019526802,"gmtModify":1787019528974,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","text":"$海致科技集团(02706)$ 从公司基本面看，2025年Atlas智能体业务收入同比增长68.4%，成为第二增长曲线","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/598021342016776","isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":591507265347888,"gmtCreate":1785379345053,"gmtModify":1785379347290,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","text":"$同源康医药-B(02410)$ 同源康上方有压力，这是不可避免的，但是引入齐鲁制药后，也有很多的资金流入进来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/591507265347888","isVote":1,"tweetType":1,"viewCount":861,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":591371377570768,"gmtCreate":1785379312761,"gmtModify":1785379314894,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 今天港股形势还可以，海致什么时候来个触底大反弹呢","listText":"<a href=\"https://laohu8.com/S/02706\">$海致科技集团(02706)$ </a> 今天港股形势还可以，海致什么时候来个触底大反弹呢","text":"$海致科技集团(02706)$ 今天港股形势还可以，海致什么时候来个触底大反弹呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/591371377570768","isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":588071343445112,"gmtCreate":1784603546050,"gmtModify":1784603548030,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","listText":"<a href=\"https://laohu8.com/S/02729\">$凯乐士科技(02729)$ </a> 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","text":"$凯乐士科技(02729)$ 根据弗若斯特沙利文数据，按2024年的收入计算，凯乐士科技位列中国前五大综合智能场内物流机器人公司","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/588071343445112","isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":588069977735200,"gmtCreate":1784603285224,"gmtModify":1784603287292,"author":{"id":"156361281180936","authorId":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"156361281180936","authorIdStr":"156361281180936"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","text":"$同源康医药-B(02410)$ 同源康目前涨幅还不错，有机会进一步升起来，争取早点破10块","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/588069977735200","isVote":1,"tweetType":1,"viewCount":881,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}
